Cargando…
Oncostatin M promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the NF-κB pathway in THP-1 macrophages and promotes the progression of atherosclerosis
BACKGROUND: Oncostatin M (OSM) is reported to be involved in many stages of atherosclerosis, including endothelial dysfunction, chronic inflammation, and smooth muscle cell migration. This study explored the effects of OSM on foam cell formation and its corresponding molecular mechanisms. METHODS: T...
Autores principales: | Liu, Cheng, Wu, Jiang, Jia, Haiyun, Lu, Caixia, Liu, Junjun, Li, Yongxin, Guo, Mingjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096425/ https://www.ncbi.nlm.nih.gov/pubmed/35571419 http://dx.doi.org/10.21037/atm-22-560 |
Ejemplares similares
-
K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages
por: Zhou, Zhenfeng, et al.
Publicado: (2020) -
LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013) -
NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019) -
Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation
por: Sun, Zhenzhen, et al.
Publicado: (2019) -
Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis
por: Bian, Weihua, et al.
Publicado: (2020)